US Stock MarketDetailed Quotes
AYTU Aytu BioPharma
- 2.2900
- 0.00000.00%
Close Oct 18 16:00 ET
- 2.2900
- 0.00000.00%
Post 16:46 ET
14.08MMarket Cap-800P/E (TTM)
2.3000High2.2654Low7.20KVolume2.2800Open2.2900Pre Close16.37KTurnover0.16%Turnover RatioLossP/E (Static)6.15MShares3.450052wk High0.51P/B10.18MFloat Cap2.111152wk Low--Dividend TTM4.44MShs Float27279.9864Historical High--Div YieldTTM1.51%Amplitude1.3800Historical Low2.2740Avg Price1Lot Size
Aytu BioPharma Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 72.94%-1.39M | -108.41%-788K | 91.26%-254K | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 231.99%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M |
| Net income from continuing operations | 7.08%-15.84M | -87.91%-4.62M | 59.90%-2.89M | 96.71%-220K | -1,058.35%-8.12M | 84.33%-17.05M | 84.73%-2.46M | 86.49%-7.2M | 42.04%-6.69M | 97.48%-701K |
| Operating gains losses | 191.88%4.4M | -177.37%-1.06M | 60.47%-1.02M | 141.13%577K | 369.60%5.91M | -1,184.99%-4.79M | 1,060.84%1.37M | -1,329.44%-2.57M | ---1.4M | ---2.19M |
| Depreciation and amortization | -6.16%8.27M | -8.13%1.94M | -12.45%1.92M | -1.22%2.18M | -3.09%2.23M | -13.12%8.82M | -4.68%2.12M | -14.84%2.19M | -17.53%2.21M | -14.05%2.3M |
| Other non cash items | 411.91%1.26M | 398.23%844K | 125.47%161K | -55.10%110K | -46.82%142K | 78.17%-403K | 61.96%-283K | 46.71%-632K | 181.61%245K | 9,000.00%267K |
| Change In working capital | 19.64%-4.66M | -101.71%-42K | -90.30%416K | -49.59%-3.68M | 86.60%-1.35M | 46.62%-5.8M | 139.57%2.46M | 222.48%4.29M | -80.90%-2.46M | -4,878.67%-10.08M |
| -Change in receivables | 174.37%5.32M | 21.73%6.31M | 93.86%-522K | -79.86%479K | 84.79%-945K | -209.49%-7.15M | -11.96%5.18M | -87.29%-8.5M | 277.60%2.38M | -195.20%-6.21M |
| -Change in inventory | 19.42%-2.91M | -98.39%-1.23M | 33.58%-534K | -48.10%-117K | 51.38%-1.02M | -377.83%-3.61M | -151.49%-622K | -222.00%-804K | 79.74%-79K | -1,082.02%-2.1M |
| -Change in prepaid assets | 80.50%1.53M | -85.08%664K | 18.05%1.18M | 48.45%-1.45M | 162.47%1.13M | -62.03%846K | 441.24%4.45M | -69.62%1M | -28.97%-2.81M | -745.52%-1.8M |
| -Change in payables and accrued expense | -307.81%-12.45M | -20.43%-5.74M | -98.03%248K | -38.68%-2.71M | -4,111.32%-4.25M | 128.56%5.99M | 66.29%-4.76M | 530.81%12.6M | -173.97%-1.95M | 101.62%106K |
| -Change in other working capital | 305.50%3.85M | 97.48%-45K | 671.43%40K | 2,800.00%108K | 5,300.00%3.74M | -3,844.00%-1.87M | -89,350.00%-1.79M | -800.00%-7K | 95.83%-4K | -148.98%-72K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 72.94%-1.39M | -108.41%-788K | 91.26%-254K | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 231.99%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -181.20%-329K | 78.06%-34K | -4,600.00%-45K | -3,380.00%-174K | -280.95%-76K | 96.40%-117K | -278.05%-155K | 101.43%1K | 99.84%-5K | 148.84%42K |
| Net other investing changes | -181.20%-329K | 78.06%-34K | -1,025.00%-45K | ---174K | -280.95%-76K | -67.14%-117K | -15,400.00%-155K | 90.24%-4K | --0 | 216.67%42K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -181.20%-329K | 78.06%-34K | -4,600.00%-45K | -3,380.00%-174K | -280.95%-76K | 96.40%-117K | -278.05%-155K | 101.43%1K | 99.84%-5K | 148.84%42K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -114.23%-1.26M | 119.76%1.07M | -79.48%530K | 93.24%-126K | -120.17%-2.73M | 479.80%8.87M | -383.80%-5.4M | 69.82%2.58M | -128.30%-1.87M | 348.11%13.56M |
| Net issuance payments of debt | 19.44%-1.89M | 79.26%-1.84M | -81.73%530K | 66.46%-212K | -108.71%-370K | 55.07%-2.35M | -2,304.73%-8.86M | 159.83%2.9M | -123.72%-632K | 223.52%4.25M |
| Net common stock issuance | -77.74%3.47M | 31.92%3.38M | --0 | -92.57%86K | --0 | 33.19%15.58M | 354.77%2.56M | -81.73%1.44M | -74.39%1.16M | 3,292.83%10.42M |
| Net other financing activities | 34.86%-2.84M | -153.01%-475K | --0 | --0 | -113.55%-2.36M | 11.82%-4.36M | 274.66%896K | -16.74%-1.76M | -303.72%-2.39M | 52.53%-1.11M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -114.23%-1.26M | 119.76%1.07M | -79.48%530K | 93.24%-126K | -120.17%-2.73M | 479.80%8.87M | -383.80%-5.4M | 69.82%2.58M | -128.30%-1.87M | 348.11%13.56M |
| Net cash flow | ||||||||||
| Beginning cash position | 18.72%22.99M | 3.03%19.76M | 0.14%19.53M | -16.16%19.96M | 18.72%22.99M | -61.20%19.36M | -30.54%19.18M | -44.72%19.5M | -41.29%23.81M | -61.20%19.36M |
| Current changes in cash | -182.18%-2.98M | -93.54%246K | 171.74%231K | 89.91%-435K | -167.87%-3.02M | 111.87%3.63M | 146.12%3.81M | 95.80%-322K | 18.42%-4.31M | 147.65%4.45M |
| End cash Position | -12.96%20.01M | -12.96%20.01M | 3.03%19.76M | 0.14%19.53M | -16.16%19.96M | 18.72%22.99M | 18.72%22.99M | -30.54%19.18M | -44.72%19.5M | -41.29%23.81M |
| Free cash flow | 72.94%-1.39M | -108.41%-788K | 91.26%-254K | 94.47%-135K | 97.69%-211K | 82.21%-5.13M | 231.99%9.37M | 68.12%-2.91M | 72.34%-2.44M | -141.31%-9.15M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data